145 related articles for article (PubMed ID: 11156884)
1. Key role of the P2Y(1) receptor in tissue factor-induced thrombin-dependent acute thromboembolism: studies in P2Y(1)-knockout mice and mice treated with a P2Y(1) antagonist.
Léon C; Freund M; Ravanat C; Baurand A; Cazenave JP; Gachet C
Circulation; 2001 Feb; 103(5):718-23. PubMed ID: 11156884
[TBL] [Abstract][Full Text] [Related]
2. Defective platelet aggregation and increased resistance to thrombosis in purinergic P2Y(1) receptor-null mice.
Léon C; Hechler B; Freund M; Eckly A; Vial C; Ohlmann P; Dierich A; LeMeur M; Cazenave JP; Gachet C
J Clin Invest; 1999 Dec; 104(12):1731-7. PubMed ID: 10606627
[TBL] [Abstract][Full Text] [Related]
3. MRS2500 [2-iodo-N6-methyl-(N)-methanocarba-2'-deoxyadenosine-3',5'-bisphosphate], a potent, selective, and stable antagonist of the platelet P2Y1 receptor with strong antithrombotic activity in mice.
Hechler B; Nonne C; Roh EJ; Cattaneo M; Cazenave JP; Lanza F; Jacobson KA; Gachet C
J Pharmacol Exp Ther; 2006 Feb; 316(2):556-63. PubMed ID: 16236815
[TBL] [Abstract][Full Text] [Related]
4. The P2Y(1) receptor as a target for new antithrombotic drugs: a review of the P2Y(1) antagonist MRS-2179.
Baurand A; Gachet C
Cardiovasc Drug Rev; 2003; 21(1):67-76. PubMed ID: 12595918
[TBL] [Abstract][Full Text] [Related]
5. Effects of inhibition of P2Y(1) and P2Y(12) on whole blood clotting, coagulum elasticity and fibrinolysis resistance studied with free oscillation rheometry.
Ramström S; Rånby M; Lindahl TL
Thromb Res; 2003 Mar; 109(5-6):315-22. PubMed ID: 12818256
[TBL] [Abstract][Full Text] [Related]
6. The relative importance of the ADP receptors, P2Y12 and P2Y1, in thrombin-induced platelet activation.
Nylander S; Mattsson C; Ramström S; Lindahl TL
Thromb Res; 2003; 111(1-2):65-73. PubMed ID: 14644082
[TBL] [Abstract][Full Text] [Related]
7. Platelet ADP receptors contribute to the initiation of intravascular coagulation.
Leon C; Alex M; Klocke A; Morgenstern E; Moosbauer C; Eckly A; Spannagl M; Gachet C; Engelmann B
Blood; 2004 Jan; 103(2):594-600. PubMed ID: 12969982
[TBL] [Abstract][Full Text] [Related]
8. The P2Y1 receptor plays an essential role in the platelet shape change induced by collagen when TxA2 formation is prevented.
Mangin P; Ohlmann P; Eckly A; Cazenave JP; Lanza F; Gachet C
J Thromb Haemost; 2004 Jun; 2(6):969-77. PubMed ID: 15140133
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of the platelet P2Y12 receptor for adenosine diphosphate potentiates the antiplatelet effect of prostacyclin.
Cattaneo M; Lecchi A
J Thromb Haemost; 2007 Mar; 5(3):577-82. PubMed ID: 17155953
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of localized thrombosis in P2Y1-deficient mice and rodents treated with MRS2179, a P2Y1 receptor antagonist.
Lenain N; Freund M; Léon C; Cazenave JP; Gachet C
J Thromb Haemost; 2003 Jun; 1(6):1144-9. PubMed ID: 12871312
[TBL] [Abstract][Full Text] [Related]
11. Novel antagonists acting at the P2Y(1) purinergic receptor: synthesis and conformational analysis using potentiometric and nuclear magnetic resonance titration techniques.
Raboisson P; Baurand A; Cazenave JP; Gachet C; Retat M; Spiess B; Bourguignon JJ
J Med Chem; 2002 Feb; 45(4):962-72. PubMed ID: 11831909
[TBL] [Abstract][Full Text] [Related]
12. Both ADP and thrombin regulate arteriolar thrombus stabilization and embolization, but are not involved in initial hemostasis as induced by micropuncture.
van Gestel MA; Reitsma S; Slaaf DW; Heijnen VV; Feijge MA; Lindhout T; van Zandvoort MA; Elg M; Reneman RS; Heemskerk JW; Egbrink MG
Microcirculation; 2007; 14(3):193-205. PubMed ID: 17454672
[TBL] [Abstract][Full Text] [Related]
13. The platelet P2 receptors in thrombosis.
Gachet C; Hechler B
Semin Thromb Hemost; 2005 Apr; 31(2):162-7. PubMed ID: 15852219
[TBL] [Abstract][Full Text] [Related]
14. Inactivation of the human P2Y12 receptor by thiol reagents requires interaction with both extracellular cysteine residues, Cys17 and Cys270.
Ding Z; Kim S; Dorsam RT; Jin J; Kunapuli SP
Blood; 2003 May; 101(10):3908-14. PubMed ID: 12560222
[TBL] [Abstract][Full Text] [Related]
15. Identification, characterization, and inhibition of the platelet ADP receptors.
Gachet C
Int J Hematol; 2001 Dec; 74(4):375-81. PubMed ID: 11794691
[TBL] [Abstract][Full Text] [Related]
16. Synergistic action between inhibition of P2Y12/P2Y1 and P2Y12/thrombin in ADP- and thrombin-induced human platelet activation.
Nylander S; Mattsson C; Ramström S; Lindahl TL
Br J Pharmacol; 2004 Aug; 142(8):1325-31. PubMed ID: 15265806
[TBL] [Abstract][Full Text] [Related]
17. Molecular identification and characterization of the platelet ADP receptor targeted by thienopyridine antithrombotic drugs.
Foster CJ; Prosser DM; Agans JM; Zhai Y; Smith MD; Lachowicz JE; Zhang FL; Gustafson E; Monsma FJ; Wiekowski MT; Abbondanzo SJ; Cook DN; Bayne ML; Lira SA; Chintala MS
J Clin Invest; 2001 Jun; 107(12):1591-8. PubMed ID: 11413167
[TBL] [Abstract][Full Text] [Related]
18. The P2 receptors in platelet function.
Hechler B; Cattaneo M; Gachet C
Semin Thromb Hemost; 2005 Apr; 31(2):150-61. PubMed ID: 15852218
[TBL] [Abstract][Full Text] [Related]
19. 2-Chloro N(6)-methyl-(N)-methanocarba-2'-deoxyadenosine-3',5'-bisphosphate is a selective high affinity P2Y(1) receptor antagonist.
Boyer JL; Adams M; Ravi RG; Jacobson KA; Harden TK
Br J Pharmacol; 2002 Apr; 135(8):2004-10. PubMed ID: 11959804
[TBL] [Abstract][Full Text] [Related]
20. Differential involvement of the P2Y1 and P2Y12 receptors in platelet procoagulant activity.
Leon C; Ravanat C; Freund M; Cazenave JP; Gachet C
Arterioscler Thromb Vasc Biol; 2003 Oct; 23(10):1941-7. PubMed ID: 12933533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
